User profiles for J. Lieberman

Jay Lieberman

Professor of Medicine. The University of Tennessee Health Sciences Center
Verified email at uthsc.edu
Cited by 4655

The role of growth factors in the repair of bone: biology and clinical applications

JR Lieberman, A Daluiski, TA Einhorn - JBJS, 2002 - journals.lww.com
➤ There are a number of potential clinical applications for growth factors in the enhancement
of bone repair, including acceleration of fracture-healing, treatment of established …

Prevention of venous thromboembolism

…, W Geerts, JA Heit, M Knudson, JR Lieberman… - Chest, 1998 - journal.chestnet.org
The rationale for prophylaxis of venous thromboembolism (VfE) is based on the clinically silent
nature of the disease, the relatively high prevalence among hospitahzed patients, and the …

Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis

…, DM Lang, ES Lang, JA Lieberman, J Portnoy… - Journal of Allergy and …, 2020 - Elsevier
Anaphylaxis is an acute, potential life-threatening systemic allergic reaction that may have a
wide range of clinical manifestations. Severe anaphylaxis and/or the need for repeated …

[HTML][HTML] Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

…, W Ageno, LC Borris, JR Lieberman… - … England Journal of …, 2008 - Mass Medical Soc
Background We investigated the efficacy of rivaroxaban, an orally active direct factor Xa
inhibitor, in preventing venous thrombosis after total knee arthroplasty. Methods In this …

Anaphylaxis—a practice parameter update 2015

…, S Kemp, D Khan, D Ledford, J Lieberman… - Annals of Allergy …, 2015 - annallergy.org
This is the fourth iteration of this parameter entitled “The Diagnosis and Management of
Anaphylaxis.” The first anaphylaxis parameter was published in 1998 and the last in 2010. The …

The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats

JR Lieberman, A Daluiski, S Stevenson, LA JOLLA… - JBJS, 1999 - journals.lww.com
Background: Recombinant human bone morphogenetic proteins (rhBMPs) can induce bone
formation, but the inability to identify an ideal delivery system limits their clinical application. …

COVID-19: pandemic contingency planning for the allergy and immunology clinic

…, D Mack, AK Ellis, D Lang, J Lieberman… - The Journal of Allergy …, 2020 - Elsevier
In the event of a global infectious pandemic, drastic measures may be needed that limit or
require adjustment of ambulatory allergy services. However, no rationale for how to prioritize …

Osteonecrosis of the hip: management in the 21st century.

JR Lieberman, DJ Berry, MA Mont… - Instructional course …, 2003 - europepmc.org
Osteonecrosis of the femoral head is a progressive condition that often leads to collapse of
the femoral head. The ultimate goal in the treatment for osteonecrosis of the hip is …

The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and …

…, D Lang, D Ledford, M Levin, J Lieberman… - The Journal of Allergy …, 2021 - Elsevier
Concerns for anaphylaxis may hamper severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
immunization efforts. We convened a multidisciplinary group of international …

Bone morphogenetic protein-2: biology and applications.

…, MR Urist, KM Lyons, JR Lieberman - … Research (1976-2007 …, 1996 - journals.lww.com
Bone morphogenetic protein-2 is a low molecular weight glycoprotein, classified as a
morphogen. The sine qua non of bone morphogenetic protein is consistently reproducible …